Outlook: ASX looks up after Wall St lead

Market Reports

Following yesterday’s steep falls the SPI is pointing to a higher start for the Australian share market after Wall Street lifted into the new week. Closer to home the Australia dollar has risen back above $US0.77 and the price of gold and oil have risen but the iron ore price has hit a fresh six-year low. 
 
Global markets
 
Wall Street recovered some on Friday’s falls yesterday: The Dow Jones Industrial Average gained 0.8 per cent to close at 17,996, the S&P 500 gained 0.4 per cent to close at 2,079 and the Nasdaq gained 0.3 per cent to close at 4,942.
 
European markets finished mixed on Monday: London's FTSE 100 eased 0.5 per cent, France's CAC 40 fell 0.6 per cent and Germany's DAX firmed 0.3 per cent.
 
Asian markets ended mixed on Monday: Japan’s Nikkei fell almost 1 per cent, Hong Kong’s Hang Seng lost 0.2 per cent, and China’s Shanghai Composite jumped 1.9 per cent.
 
The Australian share market sank 1.3 per cent on Monday after America’s better than expected jobs report fuelled speculation rates could rise sooner than later: The S&P/ASX 200 index plunged 78 points to close at 5,821. On the futures market the SPI is 12 points higher. 
 
Currencies 
 
The Australian dollar at 7:30am was buying $US0.7708, 50.97 Pence Sterling, 93.38 Yen and 71.04 Euro cents.
 
Economic news due out today 
 
National Australia Bank Limited (ASX:NAB): Business Survey for February
 
ANZ Banking Group (ASX:ANZ)-Roy Morgan: Weekly Consumer Confidence index
 
Company news
 
Regeneus Limited (ASX:RGS) has reported positive preclinical results for its off-the-shelf cell therapy treatment for osteoarthritis. The regenerative medicine company says the results confirm Progenza is safe and prevents disease progression in a model of osteoarthritis. Regeneus has also affirmed Progenza is on track to move into the clinic for a “First-in-Human” study. Shares in Regeneus rose 6.45 per cent to close at $0.165 on Monday. 
 
Orthocell Limited (ASX:OCC) has been granted ethical approval for a pilot clinical study using Celgro in dental procedures. The regenerative medicine company says the study is to demonstrate Celgro can be used as a barrier membrane to allow bone growth without competition from other connective tissue. Orthocell has described Celgro as a breakthrough regenerative medicine. Shares in Orthocell rose 2.85 per cent to close at $0.36 on Monday. 
 
Commodities 
 
Gold has gained $2.20 to $US1,167 an ounce for the April contract on Comex. 
Silver has slipped $0.03 to $15.78 for May. 
Copper has risen $0.06 to $2.67 a pound. 
Oil has risen $0.39 to $US50 a barrel for April light crude in New York. 

Ex-dividends
 
Dick Smith Holdings Limited (ASX:DSH) paying a 7 cent full franked dividend
Fiducian Group Limited (ASX:FID) paying a 4.5 cent full franked dividend
InvoCare Limited (ASX:IVC) paying a 20.75 cent full franked dividend
Keybridge Capital Limited (ASX:KBC) paying a 0.25 cent full franked dividend
Logicamms Limited (ASX:LCM) paying a 3.5 cent, 50 per cent franked dividend
Matrix C & E Limited (ASX:MCE) paying a 2 cent full franked dividend
Monadelphous Group Limited (ASX:MND) paying a 46 cent full franked dividend
Mighty River Power Limited (ASX:MYT) paying a 5.3768 cent unfranked dividend
Orora Limited (ASX:ORA) paying a 3.5 cent unfranked dividend
Prophecy International Holdings Limited (ASX:PRO) 2 cent full franked dividend
RCR Tomlinson Limited (ASX:RCR) paying a 3.5 cent full franked dividend
Sedgman Limited (ASX:SDM) paying a 3.5 cent full franked dividend
Sandfire Resources Limited (ASX:SFR) paying a 3 cent unfranked dividend
Slater & Gordon Limited (ASX:SGH) paying a 3.5 cent, 40 per cent franked dividend
Tox Free Solutions Limited (ASX:TOX) paying a 4 cent full franked dividend

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.